Merck & Co Inc/ US58933Y1055 /
6/28/2022 9:59:59 PM | Chg. -2.56 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
91.90USD | -2.71% | 650,141 Turnover: 60.03 mill. |
-Bid Size: - | -Ask Size: - | 232.37 bill.USD | 2.83% | 17.81 |
GlobeNewswire
1/11
Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
GlobeNewswire
1/10
NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal ...